AGTC Partners, L.P. - Net Worth and Insider Trading

AGTC Partners, L.P. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, AGTC Partners, L.P. owns 2 companies in total, including BG Medicine Inc (BGMD) , and Acceleron Pharma Inc (XLRN) .

Click here to see the complete history of AGTC Partners, L.P.’s form 4 insider trades.

Insider Ownership Summary of AGTC Partners, L.P.

Ticker Comapny Transaction Date Type of Owner
BGMD BG Medicine Inc 2015-07-27 10 percent owner
XLRN Acceleron Pharma Inc 2013-09-18 10 percent owner

AGTC Partners, L.P. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

AGTC Partners, L.P. Ownership Network

Ownership Network List of AGTC Partners, L.P.

No Data

Ownership Network Relation of AGTC Partners, L.P.


AGTC Partners, L.P. Owned Company Details

What does BG Medicine Inc do?

Who are the key executives at BG Medicine Inc?

AGTC Partners, L.P. is the 10 percent owner of BG Medicine Inc. Other key executives at BG Medicine Inc include director & 10 percent owner Noubar Afeyan , 10 percent owner Flagship Pioneering Inc. , and 10 percent owner Agtc Advisors Fund Lp .

BG Medicine Inc (BGMD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of BG Medicine Inc (BGMD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BG Medicine Inc (BGMD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

BG Medicine Inc (BGMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

BG Medicine Inc Insider Transactions

No Available Data

AGTC Partners, L.P. Mailing Address

Above is the net worth, insider trading, and ownership report for AGTC Partners, L.P.. You might contact AGTC Partners, L.P. via mailing address: C/o Flagship Ventures One Memorial Drive, 7th Floor Cambridge Ma 02142.

Discussions on AGTC Partners, L.P.

No discussions yet.